Fulcrum Therapeutics, Inc. (Nasdaq:FULC)

Health Care/Life Sciences • Biotechnology

CIK 1680581

Company

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.

Address
26 Landsdowne Street
Cambridge, Massachusetts 02139

Employees
76

Stock Info

Close
$10.96

Day Range
10.86 - 11.40

52 Week Range
2.25 - 11.51

Average volume
668.31K

Short Interest
3.22M (02/15/24)

% of Float Shorted
5.48%

Market Cap
$701.73M

Revenue
$2.81M

Net Income
N/A

2020 Sales Growth
N/A

Rev. per Employee
$36.91K

P/E Ratio
N/A

EPS
-$1.59

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Alexander C Sapir MBA

Director
Robert J Gould PhD

Chairman
Kathryn Haviland MBA

Independent Director
James Arthur Geraghty

Independent Director
Sonja L Banks

Independent Director
Katina Dorton MBA

Independent Director
James J Collins PhD

Independent Director
R. Alan B Ezekowitz PhD

SEC filings

Date	Form	Event
23 Aug, 2024	SC 13G/A
23 Aug, 2024	4
22 Aug, 2024	8-K
31 Jul, 2024	S-8
31 Jul, 2024	10-Q
31 Jul, 2024	8-K
8 Jul, 2024	4
18 Jun, 2024	3
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
17 Jun, 2024	8-K
13 May, 2024	8-K
13 May, 2024	10-Q
9 May, 2024	4
25 Apr, 2024	EFFECT
24 Apr, 2024	CORRESP
19 Apr, 2024	DEFA14A
19 Apr, 2024	ARS
19 Apr, 2024	DEF 14A
20 Mar, 2024	3
20 Mar, 2024	4
8 Mar, 2024	4
8 Mar, 2024	144
5 Mar, 2024	4
1 Mar, 2024	UPLOAD
27 Feb, 2024	S-3
27 Feb, 2024	8-K
27 Feb, 2024	S-8
27 Feb, 2024	10-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
9 Feb, 2024	SC 13G/A
7 Feb, 2024	SC 13G/A
30 Jan, 2024	4
30 Jan, 2024	4
30 Jan, 2024	4
7 Nov, 2023	8-K
7 Nov, 2023	10-Q
2 Oct, 2023	8-K
22 Aug, 2023	8-K
9 Aug, 2023	4
9 Aug, 2023	3
3 Aug, 2023	10-Q
3 Aug, 2023	8-K	CEO Change
10 Jul, 2023	8-K
7 Jul, 2023	SC 13G/A
3 Jul, 2023	3
29 Jun, 2023	4
29 Jun, 2023	4
29 Jun, 2023	4
29 Jun, 2023	4
29 Jun, 2023	4
29 Jun, 2023	4
29 Jun, 2023	4
26 Jun, 2023	10-K/A
26 Jun, 2023	10-K/A
23 Jun, 2023	10-K/A
9 Jun, 2023	8-K
15 May, 2023	8-K	CEO Change
15 May, 2023	10-Q
11 May, 2023	4
28 Apr, 2023	ARS
28 Apr, 2023	DEFA14A
28 Apr, 2023	4
28 Apr, 2023	4
28 Apr, 2023	DEF 14A
18 Apr, 2023	PRE 14A
5 Apr, 2023	8-K
9 Mar, 2023	S-8
9 Mar, 2023	10-K
9 Mar, 2023	8-K
6 Mar, 2023	SC 13G
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
13 Feb, 2023	4
13 Feb, 2023	4
13 Feb, 2023	SC 13G/A
13 Feb, 2023	4
13 Feb, 2023	4
9 Feb, 2023	SC 13G/A
9 Feb, 2023	SC 13G/A
1 Feb, 2023	SC 13G/A
24 Jan, 2023	4
23 Jan, 2023	SC 13G/A
18 Jan, 2023	8-K
18 Jan, 2023	424B5
17 Jan, 2023	8-K
17 Jan, 2023	424B5
13 Jan, 2023	4
6 Jan, 2023	SC 13G/A
6 Jan, 2023	4
4 Jan, 2023	8-K	CEO Change
29 Dec, 2022	4
21 Dec, 2022	4
16 Dec, 2022	4
15 Dec, 2022	4
9 Nov, 2022	3
9 Nov, 2022	4
8 Nov, 2022	8-K
8 Nov, 2022	10-Q
19 Oct, 2022	8-K
26 Aug, 2022	SC 13G
26 Aug, 2022	3
23 Aug, 2022	8-K
17 Aug, 2022	424B5
17 Aug, 2022	8-K
15 Aug, 2022	424B5
11 Aug, 2022	4
11 Aug, 2022	10-Q
11 Aug, 2022	4
11 Aug, 2022	3
11 Aug, 2022	8-K
11 Aug, 2022	8-K
19 Jul, 2022	4
11 Jul, 2022	8-K
29 Jun, 2022	4
29 Jun, 2022	4
29 Jun, 2022	4
29 Jun, 2022	4
29 Jun, 2022	4
29 Jun, 2022	4
29 Jun, 2022	4
22 Jun, 2022	SC 13G
10 Jun, 2022	8-K
9 Jun, 2022	8-K
8 Jun, 2022	4
6 Jun, 2022	4
6 Jun, 2022	8-K
10 May, 2022	8-K
10 May, 2022	424B5
10 May, 2022	4
9 May, 2022	POS EX
9 May, 2022	8-K
9 May, 2022	10-Q
28 Apr, 2022	DEF 14A
28 Apr, 2022	DEFA14A
28 Apr, 2022	EFFECT
11 Apr, 2022	4
5 Apr, 2022	4
14 Mar, 2022	3
10 Mar, 2022	SC 13G
10 Mar, 2022	8-K
9 Mar, 2022	SC 13G
3 Mar, 2022	8-K
3 Mar, 2022	POS AM
3 Mar, 2022	S-8
3 Mar, 2022	POSASR
3 Mar, 2022	10-K
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
9 Feb, 2022	SC 13G/A
4 Feb, 2022	SC 13G
27 Jan, 2022	S-8
21 Jan, 2022	4
21 Jan, 2022	4
21 Jan, 2022	4
21 Jan, 2022	4
21 Jan, 2022	4
10 Jan, 2022	3
10 Jan, 2022	4
10 Jan, 2022	8-K
7 Jan, 2022	5
4 Jan, 2022	8-K
9 Dec, 2021	4
9 Dec, 2021	3
6 Dec, 2021	8-K
17 Nov, 2021	8-K
12 Nov, 2021	4
12 Nov, 2021	4
4 Nov, 2021	8-K
4 Nov, 2021	S-3ASR
4 Nov, 2021	10-Q
27 Sep, 2021	SC 13G/A
24 Sep, 2021	4
24 Sep, 2021	4
10 Sep, 2021	SC 13G/A
12 Aug, 2021	8-K
12 Aug, 2021	4
12 Aug, 2021	424B5
12 Aug, 2021	4
11 Aug, 2021	S-3MEF
11 Aug, 2021	424B5
10 Aug, 2021	SC 13G
10 Aug, 2021	10-Q
10 Aug, 2021	8-K
29 Jun, 2021	4
29 Jun, 2021	4
29 Jun, 2021	4
29 Jun, 2021	4
24 Jun, 2021	8-K
11 Jun, 2021	8-K
11 Jun, 2021	4
11 Jun, 2021	4
11 Jun, 2021	4
11 Jun, 2021	4
11 Jun, 2021	4
11 Jun, 2021	4
12 May, 2021	4
12 May, 2021	3
6 May, 2021	8-K
6 May, 2021	10-Q
29 Apr, 2021	DEFA14A
29 Apr, 2021	DEF 14A
2 Apr, 2021	3
2 Apr, 2021	4
2 Apr, 2021	4
24 Mar, 2021	8-K
22 Mar, 2021	SEC STAFF
17 Mar, 2021	4
4 Mar, 2021	S-8
4 Mar, 2021	10-K
4 Mar, 2021	8-K	CEO Change
24 Feb, 2021	4
22 Feb, 2021	SEC STAFF
18 Feb, 2021	4
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
11 Feb, 2021	SC 13G/A
10 Feb, 2021	4
10 Feb, 2021	3
8 Feb, 2021	SC 13G/A
4 Feb, 2021	4
27 Jan, 2021	4
27 Jan, 2021	4
25 Jan, 2021	4
22 Jan, 2021	4
20 Jan, 2021	424B5
20 Jan, 2021	8-K
19 Jan, 2021	424B5
19 Jan, 2021	8-K

Last update:2024-03-06 13:39:17.167512

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.